We are live on ! Find out more

2,018 hedge funds and large institutions have $120B invested in Merck in 2018 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 780 increasing their positions, 868 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 77

37% more funds holding in top 10

Funds holding in top 10: 84115 (+31)

10% more call options, than puts

Call options by funds: $1.22B | Put options by funds: $1.1B

10% more capital invested

Capital invested by funds: $110B → $120B (+$10.7B)

1% more funds holding

Funds holding: 1,9932,018 (+25)

0.83% less ownership

Funds ownership: 78.21%77.38% (-0.83%)

10% less repeat investments, than reductions

Existing positions increased: 780 | Existing positions reduced: 868

Holders
2,018
Holders Change
+25
Holders Change %
+1.25%
% of All Funds
46.19%
Holding in Top 10
115
Holding in Top 10 Change
+31
Holding in Top 10 Change %
+36.9%
% of All Funds
2.63%
New
120
Increased
780
Reduced
868
Closed
77
Calls
$1.22B
Puts
$1.1B
Net Calls
+$112M
Net Calls Change
-$116M
Name Holding Trade Value Shares
Change
Change in
Stake
RA
1351
Rational Advisors
New York
$832K -$789K -13,989 -49%
CGA
1352
Crescent Grove Advisors
Illinois
$832K +$169 +3 +0%
FCMT
1353
Founders Capital Management (Texas)
Texas
$831K +$85.8K +1,521 +12%
NHC
1354
Nicholas Hoffman & Company
Georgia
$830K -$11.1K -197 -1%
PIA
1355
Peachtree Investment Advisors
Georgia
$822K -$59.1K -1,048 -7%
JCM
1356
Jacobi Capital Management
Pennsylvania
$817K +$123K +2,180 +18%
SAM
1357
Security Asset Management
New York
$816K -$16.1K -285 -2%
CAN
1358
Claraphi Advisory Network
United States
$810K -$19.2K -340 -2%
SRAM
1359
Stone Ridge Asset Management
New York
$808K +$174K +3,080 +28%
Verition Fund Management
1360
Verition Fund Management
Connecticut
$807K -$4.09M -72,481 -84%
BDF
1361
Balasa Dinverno & Foltz
$806K +$70.4K +1,247 +10%
SCG
1362
Sonata Capital Group
Washington
$805K +$29.7K +526 +4%
TA
1363
Tiedemann Advisors
New York
$803K +$388K +6,878 +100%
LRPA
1364
L. Roy Papp & Associates
Arizona
$798K -$182K -3,219 -19%
HJGA
1365
Hardman Johnston Global Advisors
Connecticut
$798K
FBC
1366
Fairfield, Bush & Co
Connecticut
$797K -$21K -372 -3%
MAM
1367
Mastrapasqua Asset Management
Tennessee
$797K -$16K -283 -2%
SOAMC
1368
Spirit of America Management Corp
New York
$795K
NJBEST
1369
New Jersey Better Educational Savings Trust
New Jersey
$789K -$59.1K -1,048 -7%
ADL
1370
Asset Dedication LLC
California
$789K +$61.6K +1,092 +9%
ARMT
1371
Amica Retiree Medical Trust
Rhode Island
$786K
CPIG
1372
Chicago Partners Investment Group
Illinois
$786K +$428K +7,584 +127%
WSC
1373
Wellington Shields & Co
New York
$785K
CC
1374
Cadinha & Co
Hawaii
$784K +$24.6K +436 +3%
FBT
1375
First Bank & Trust
South Dakota
$780K -$655K -11,607 -46%

MRK Hedge Fund Activity: Q2 2018 in Review

2,018 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2018, worth a combined $120B — up 9.7% from $110B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new MRK positions and 77 closed out — a net gain of 43 holders — while 780 added to existing stakes and 868 trimmed.

The largest buyer was Capital World Investors, adding an estimated $904M. The largest seller was Dodge & Cox, cutting an estimated $620M.

  • 2,018 institutional investors held Merck (MRK) as of Q2 2018, up from 1,993 in Q1 2018.
  • Funds reported $120B of Merck stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 120 funds opened new Merck positions in Q2 2018 and 77 closed out, a net change of +43 holders.
  • The largest Merck buyer in Q2 2018 was Capital World Investors, an estimated $904M added.
  • The largest Merck seller in Q2 2018 was Dodge & Cox, an estimated $620M sold.

Based on aggregated 13F filings for Q2 2018.